Telman Deborah H
Known title: EVP, Corporate Affairs & GCCIK: 0001860008
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Gilead Signs $1.9B Deal With Vir For T-Cell Engagers. Gilead Sciences has entered a $1.9 billion partnership with Vir to develop next-generation T-cell engagers, a move aimed at expanding its oncology pipeline. This strategic agreement coincides with the stock reaching record highs as investors show renewed interest in the healthcare sector. The deal provides a new catalyst for the company ahead of its scheduled third-quarter financial results release.
Transaction History
| ATRC | ▲ Buy | Grant | 6,144 | $0 | 5/18/2026 | View on chart |
| GILD | ▼ Sell | Open Market | 17,181 | $2.1M | 11/12/2025 | View on chart |
| GILD | ▼ Sell | Open Market | 35,965 | $4.4M | 11/12/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 500 | $30K | 11/12/2025 | View on chart |
| GILD | ▼ Sell | Open Market | 500 | $61K | 11/12/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 17,181 | $1.3M | 11/12/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 35,965 | $2.2M | 11/12/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 241 | $29K | 10/25/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 515 | — | 10/25/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 1,315 | — | 9/10/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 634 | $73K | 9/10/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 3,823 | $444K | 7/25/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 514 | — | 7/25/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 8,229 | — | 7/25/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 1,313 | — | 6/10/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 430 | $47K | 6/10/2025 | View on chart |
| ATRC | ▲ Buy | Grant | 5,401 | $0 | 5/19/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 514 | — | 4/25/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 158 | $16K | 4/25/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 3,343 | — | 3/10/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 1,130 | $132K | 3/10/2025 | View on chart |
| GILD | ▲ Buy | Grant | 12,371 | $0 | 2/4/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 515 | — | 1/25/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 187 | $17K | 1/25/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 639 | — | 12/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 306 | $28K | 12/10/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 514 | — | 10/25/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 242 | $22K | 10/25/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 639 | — | 9/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 307 | $25K | 9/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 2,917 | $223K | 7/25/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 514 | — | 7/25/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 8,230 | — | 7/25/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 638 | — | 6/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 204 | $13K | 6/10/2024 | View on chart |
| ATRC | ▲ Buy | Grant | 7,788 | $0 | 5/13/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 158 | $10K | 4/25/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 515 | — | 4/25/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 2,555 | — | 3/10/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 846 | $64K | 3/10/2024 | View on chart |
| GILD | ▲ Buy | Grant | 4,646 | $0 | 1/31/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 514 | — | 1/25/2024 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 194 | $16K | 1/25/2024 | View on chart |
| GILD | ▲ Buy | Option Exercise | 514 | — | 10/25/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 243 | $19K | 10/25/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 8,231 | — | 7/25/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 4,174 | $322K | 7/25/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 2,058 | — | 7/25/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 3,186 | $0 | 5/25/2023 | View on chart |
| GILD | ▲ Buy | Grant | 376 | $21K | 2/15/2023 | View on chart |
| ATRC | ▲ Buy | Grant | 3,564 | $0 | 5/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
BTIG raises AtriCure price target to $63
BTIG raised its price target on AtriCure to $63. The new target sits above the current analyst consensus of $54.89 and exceeds the stock’s recent 52‑week high of $61.70. This adjustment may influence market expectations as the company trades near its recent support level of $27.47.
BTIG raises AtriCure price target to $63. BTIG raised its price target on AtriCure to $63. The new target sits above the current analyst consensus of $54.89 and exceeds the stock’s recent 52‑week high of $61.70. This adjustment may influence market expectations as the company trades near its recent support level of $27.47.